Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
White House drug shortage task force held rare in-person meeting with industry
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
Significant increase in earnings – full-year forecast raised – Biotech Investments
Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Change in Forecast Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings
Biotech’s 2024 IPO season kicks off with heavy demand for CG Oncology in $380M listing
NEW YORK — Bladder cancer drugmaker CG Oncology will debut on Nasdaq Thursday morning in what is expected to be the first of at least
GSK to acquire Aiolos Bio in $1.4 billion deal, picking up an experimental asthma drug
LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma